rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2011-3-24
|
pubmed:abstractText |
JAK2 V617F mutation is gaining more acceptance in laboratory testing as part of the differential diagnosis work-up of myeloproliferative disorders (MPD). This report is the first of its kind from Lebanon that analyzes the distribution of this mutation among a series of referred cases to a major tertiary referral center.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1945-0257
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
263-5
|
pubmed:meshHeading |
pubmed-meshheading:21198321-Adult,
pubmed-meshheading:21198321-Humans,
pubmed-meshheading:21198321-Janus Kinase 2,
pubmed-meshheading:21198321-Lebanon,
pubmed-meshheading:21198321-Mutation,
pubmed-meshheading:21198321-Myeloproliferative Disorders,
pubmed-meshheading:21198321-Polycythemia Vera,
pubmed-meshheading:21198321-Polymerase Chain Reaction,
pubmed-meshheading:21198321-Referral and Consultation,
pubmed-meshheading:21198321-Thrombocythemia, Essential
|
pubmed:year |
2011
|
pubmed:articleTitle |
JAK2 V617F gene mutation in the laboratory work-up of myeloproliferative disorders: experience of a major referral center in Lebanon.
|
pubmed:affiliation |
Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Beirut, Lebanon. rm11@aub.edu.lb
|
pubmed:publicationType |
Journal Article
|